Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Labstyle Innovat (DRIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,899
  • Shares Outstanding, K 25,940
  • Annual Sales, $ 5,170 K
  • Annual Income, $ -15,740 K
  • 36-Month Beta -1.87
  • Price/Sales 4.07
  • Price/Cash Flow N/A
  • Price/Book 2.02
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.92
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.43
  • Growth Rate Est. (year over year) +232,425.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.68 +22.06%
on 11/19/18
1.32 -37.12%
on 11/12/18
-0.26 (-23.85%)
since 10/19/18
3-Month
0.68 +22.06%
on 11/19/18
1.38 -39.86%
on 08/27/18
-0.14 (-14.43%)
since 08/20/18
52-Week
0.68 +22.06%
on 11/19/18
2.69 -69.14%
on 12/27/17
-0.83 (-50.00%)
since 11/20/17

Most Recent Stories

More News
DarioHealth's Diabetes Digital Health Solution Now Available at Best Buy

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that the Dario Blood Glucose Monitor has been included in Best Buy's...

DRIO : 0.83 (+20.29%)
DarioHealth Reports Third Quarter 2018 Results

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the third quarter ended September...

DRIO : 0.83 (+20.29%)
DarioHealth's Digital Diabetes Platform to be Made Available to 4.6 Million Customers at Giant Eagle, One of America's Largest Supermarket Chains

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has signed an agreement for the rollout of a Digital Diabetes Education...

DRIO : 0.83 (+20.29%)
DarioHealth Launches Integrated Diabetes Digital Health Solution Including Version 4.1 of Its Award-winning Dario App and DarioEngage Patient Coaching Platform

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today the launch of version 4.1 of its award-winning Dario® App for the Dario...

DRIO : 0.83 (+20.29%)
DarioHealth's Digital Health Blood Glucose Monitoring System Compatible With New iPhone XS and XS Max

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that its Dario LC(TM) Blood Glucose Monitoring System, which enables...

DRIO : 0.83 (+20.29%)
DarioHealth to Host Investor Conference Call on October 4, 2018

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will host a conference call to provide a business update for...

DRIO : 0.83 (+20.29%)
DarioHealth Chosen by Attain Health for Pilot Study to Improve Cystic Fibrosis Related Diabetes Management

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has entered into an agreement with Attain Health, a provider of integrative...

DRIO : 0.83 (+20.29%)
DarioHealth to Exhibit at American Association of Diabetes Educators Conference on August 17-20 in Baltimore

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it will exhibit the DarioEngage platform and its other digital health...

DRIO : 0.83 (+20.29%)
DarioHealth Reports First Quarter 2018 Results

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the first quarter ended on March...

DRIO : 0.83 (+20.29%)
DarioHealth Releases Next Generation Version 4.0 of its Award-Winning App

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced the availability of its award-winning next-generation app, version 4.0....

DRIO : 0.83 (+20.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade DRIO with:

Business Summary

DarioHealth Corp. creates mobile and digital tools. The company's product the Dario(TM) Smart Diabetes Management Solution, is a platform for diabetes management which combines blood glucose meter, native smart phone app, website portal and treatment tools to users living with diabetes, their doctors...

See More

Key Turning Points

2nd Resistance Point 1.02
1st Resistance Point 0.93
Last Price 0.83
1st Support Level 0.72
2nd Support Level 0.60

See More

52-Week High 2.69
Fibonacci 61.8% 1.92
Fibonacci 50% 1.69
Fibonacci 38.2% 1.45
Last Price 0.83
52-Week Low 0.68

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar